Consumer Medicine Information (CMI) summary
The
full CMI on the next page has more details. If you are worried about using this medicine,
speak to your doctor or pharmacist.
1. Why am I using Entyvio?
Entyvio contains the active ingredient vedolizumab. Entyvio is used to treat the signs
and symptoms of moderate to severe ulcerative colitis or moderate to severe Crohn’s
disease in adults who have not responded well enough or are intolerant to other treatments.
Entyvio can also be used to treat the signs and symptoms of moderate to severe pouchitis
in adult patients who have not responded well enough to antibiotics.
2. What should I know before I use Entyvio?
Do not use if you have ever had an allergic reaction to vedolizumab or any of the
ingredients listed at the end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines,
are pregnant or plan to become pregnant or are breastfeeding or plan to breastfeed.
3. What if I am taking other medicines?
Some medicines may interfere with Entyvio and affect how it works.
4. How do I use Entyvio?
Entyvio powder for injection will be given to you by your doctor or nurse, through
a drip in one of the veins in your arm (intravenous infusion) over about 30 minutes.
5. What should I know while using Entyvio?
|
Things you should do
|
Read this leaflet carefully before you start using this medicine. It contains important
information for you.
Keep this leaflet. You may need to read it again.
If you have any questions, ask your doctor, pharmacist or nurse.
|
|
Things you should not do
|
Do not stop using Entyvio without checking with your doctor.
Do not give this medicine to anyone else, even if they have the same condition as
you.
|
|
Driving or using machines
|
Be careful driving or operating machinery until you know how Entyvio affects you.
If you feel dizzy, do not drive or use tools or machines.
|
|
Looking after your medicine
|
Store in a refrigerator at 2°C to 8°C. Do not freeze.
Keep the vial in the original carton to protect from light.
|
6. Are there any side effects?
Very common: common cold, joint pain, headache. Common: fever, flu (influenza), nose
or throat infection, bronchitis, chest infection, chest discomfort, cough, throat
pain, nausea, itching, rash and redness, pain in the extremities, back pain, tiredness,
rectal bleeding. Serious side effects: allergic reactions, infections, liver injury.
Active ingredient(s):
vedolizumab
Full Consumer Medicine Information (CMI)
This leaflet provides important information about using Entyvio. It does not take
the place of talking to your doctor or pharmacist.
You should also speak to your doctor or pharmacist if you would like further information
or if you have any concerns or questions about using Entyvio.
The information in this leaflet was last updated on the date listed on the final page.
More recent information on the medicine may be available. You should ensure that you
speak to your pharmacist or doctor to obtain the most up to date information on this
medicine. You can also download the most up to date leaflet from www.takeda.com/en-au.
Those updates may contain important information about the medicine and its use of
which you should be aware.
Where to find information in this leaflet:
1. Why am I using Entyvio?
Entyvio contains the active ingredient vedolizumab. Vedolizumab is a monoclonal antibody. Monoclonal antibodies are proteins that recognise
and bind to certain special proteins in the body.
Entyvio specifically binds to a protein called integrin α4β7 present on certain white
blood cells. Integrin α4β7 can act to increase inflammation seen in ulcerative colitis,
Crohn’s disease and pouchitis. Entyvio works by blocking α4β7 integrins and so reduces
inflammation.
Ulcerative colitis
Ulcerative colitis is an inflammatory disease of the large bowel. Entyvio is used
to treat the signs and symptoms of moderate to severe ulcerative colitis in adults
who have not responded well enough or are intolerant to other treatments.
Crohn’s disease
Crohn’s disease is an inflammatory disease of the bowel. It may also affect any part
of the gut. Entyvio is used to treat the signs and symptoms of moderate to severe
Crohn’s disease in adults who have not responded well enough or are intolerant to
other treatments.
Pouchitis
Pouchitis is a disease that causes inflammation of the lining of the pouch, which
was created during surgery to treat ulcerative colitis. If you have pouchitis, you
may first be given antibiotics. If you do not respond well enough to the antibiotics,
your doctor may give you Entyvio to reduce the signs and symptoms of your disease.
2. What should I know before I use Entyvio?
Warnings
Do not use Entyvio if:
You are allergic to vedolizumab, or any of the ingredients listed at the end of this
leaflet.
Symptoms of an allergic reaction may include wheezing or difficulty breathing, hives,
itching of the skin, swelling or dizziness.
You have an active severe infection, such as for example tuberculosis, blood poisoning,
serious abscesses.
After the expiry date printed on the pack or if the packaging is damaged or shows
signs of tampering. If it has expired or is damaged return it to your pharmacist for
disposal.
Check with your doctor if you:
Have an infection, or think you have an infection.
Are going to receive any vaccination or have recently had a vaccination. Entyvio may
affect the way you respond to a vaccination.
Have any allergies to any other medicines, foods, preservatives or dyes.
Take any medicines for any other condition.
During treatment, you may be at risk of developing certain side effects. It is important
you understand these risks and how to monitor for them. See additional information
under Section
6. Are there any side effects?
Pregnancy and breastfeeding
Tell your doctor if you are pregnant or intend to become pregnant.
The effects of Entyvio in pregnant women are not known. Therefore, this medicine is
not recommended for use during pregnancy unless you and your doctor decide that the
benefit to you clearly outweighs the potential risk to your baby. Your doctor can
discuss the risks and benefits involved.
If you are a woman of childbearing potential, you should use adequate contraception
to avoid falling pregnant and continue to use it for at least 4.5 months after the
last treatment with Entyvio.
Tell your doctor if you are breastfeeding or intend to breastfeed.
Entyvio passes into breast milk and it is not known what effect this may have on your
baby.
Women who are breastfeeding or intend to breastfeed should talk to their doctor about
whether or not to use Entyvio.
Use in Children
There is not enough information to recommend the use of this medicine for children
under the age of 18 years.
3. What if I am taking other medicines?
Tell your doctor or pharmacist if you are taking any other medicines, including any
medicines, vitamins or supplements that you buy without a prescription from your pharmacy,
supermarket or health food shop.
Entyvio should not be given with other biologic medicines that suppress your immune
system as this combination has not been studied in clinical trials.
Tell your doctor if you have previously taken natalizumab (a medicine for multiple
sclerosis) or rituximab (a medicine for certain types of cancer and rheumatoid arthritis).
Your doctor will decide if you can use Entyvio.
Check with your doctor or pharmacist if you are not sure about what medicines, vitamins
or supplements you are taking and if these affect Entyvio.
4. How do I use Entyvio?
How much to use
Treatment with Entyvio is the same for ulcerative colitis, Crohn’s disease and pouchitis.
The recommended dose of Entyvio is 300 mg per infusion. Following the initial dose,
you will get additional infusions at 2 and 6 weeks and be assessed by your treating
doctor 6 to 8 weeks after you’ve completed the initial treatment doses to see how
you have responded.
For patients with Crohn’s Disease who have not shown response, your doctor may recommend
an additional dose of Entyvio at week 10.
If there has been an adequate response to the first 3 doses you may continue treatment
with further doses every 8 weeks.
For patients with ulcerative colitis or Crohn’s disease, your doctor may decide to
alter this treatment schedule to every 4 weeks depending on how well Entyvio works
for you.
How Entyvio is given
Entyvio will be given to you by your doctor or nurse, through a drip in one of the
veins in your arm (intravenous infusion) over about 30 minutes.
Your healthcare provider will monitor you during and after the Entyvio infusion for
side effects to see if you have a reaction to the treatment.
How long to take it
Continue receiving your medicine for as long as your doctor tells you.
You should not stop using Entyvio without talking with your doctor first.
If you forget to use Entyvio
If you forget or miss an appointment to receive the infusion, make another appointment
as soon as possible.
If you are not sure what to do, ask your doctor.
If you are given too much Entyvio
As Entyvio is given to you by infusion under the supervision of a doctor or nurse,
it is unlikely that you will receive too much.
However, if you experience any side effects after being given Entyvio, tell your doctor
or nurse immediately.
5. What should I know while using Entyvio?
Things you should do
When you first receive this medicine and during the course of the treatment, also
between doses, tell your doctor or pharmacist immediately if you:
Have an infection, or think you have an infection, such as if you develop chills, shivering, persistent
cough or a high fever. Some infections may become serious and possibly even life-threatening
if left untreated.
Experience signs of an allergic reaction or other reaction to the infusion such as wheezing, difficulty breathing, hives,
itching, swelling or dizziness.
Are going to receive any vaccination or have recently had a vaccination. Entyvio may affect the way you respond to a vaccination.
If you are about to be started on any new medicine, remind your doctor that you are
using Entyvio.
If you become pregnant while you are taking this medicine, tell your doctor immediately.
Call your doctor straight away if you:
Experience blurred, loss of or double vision, difficulty speaking, weakness in an
arm or a leg, a change in the way you walk or problems with your balance, persistent
numbness, decreased sensation or loss of sensation, or memory loss or confusion. These
may all be symptoms of a serious and potentially fatal brain condition known as progressive multifocal leukoencephalopathy (PML).
Remind any doctor, dentist or pharmacist you visit that you are using Entyvio.
Things you should not do
Do not use this medicine to treat any other complaints unless your doctor tells you
to.
Do not give this medicine to anyone else, even if they have the same condition as
you.
Do not stop using Entyvio without checking with your doctor.
Driving or using machines
Be careful before you drive or use any machines or tools until you know how Entyvio
affects you.
This medicine may have a minor influence on your ability to drive or use tools or
machines. A small number of patients have felt dizzy after receiving Entyvio.
If you feel dizzy, do not drive or use tools or machines.
Looking after your medicine
If you need to store Entyvio before taking it to hospital or clinic, the unopened
vial should be stored in the refrigerator at 2°C to 8°C (Refrigerate. Do not freeze).
Keep the vial in the original carton to protect from light.
Do not use this medicine after the expiry date.
Follow the instructions in the carton on how to take care of your medicine properly.
Store it in a cool dry place away from moisture, heat or sunlight; for example, do
not store it:
in the bathroom or near a sink, or
in the car or on windowsills.
Keep it where young children cannot reach it.
6. Are there any side effects?
All medicines can have side effects. If you do experience any side effects, most of
them are minor and temporary. However, some side effects may need medical attention.
Do not be alarmed by this list of possible side effects. You may not experience any
of them.
See the information below and, if you need to, ask your doctor or pharmacist if you
have any further questions about side effects.
Less serious side effects
Serious side effects
Tell your doctor or pharmacist if you notice anything else that may be making you
feel unwell.
Other side effects not listed here may occur in some people.
Reporting side effects
After you have received medical advice for any side effects you experience, you can
report side effects to the Therapeutic Goods Administration online at
www.tga.gov.au/reporting-problems . By reporting side effects, you can help provide more information on the safety of
this medicine.
Always make sure you speak to your doctor or pharmacist before you decide to stop
taking any of your medicines.
7. Product details
This medicine is only available with a doctor's prescription.
What Entyvio contains
|
Active ingredient
(main ingredient)
|
Each vial of Entyvio contains 300 mg of vedolizumab.
After reconstitution each mL of solution contains 60 mg of vedolizumab.
|
|
Other ingredients
(inactive ingredients)
|
histidine
histidine hydrochloride monohydrate
arginine hydrochloride
sucrose
polysorbate 80
|
Do not take this medicine if you are allergic to any of these ingredients.
What Entyvio looks like
Entyvio is a white to off-white powder provided in a glass vial.
Each pack of Entyvio contains one vial (AUST R 210048).
Who distributes Entyvio
Entyvio is supplied in Australia by:
Takeda Pharmaceuticals
Australia Pty Ltd
Level 39, 225 George Street
Sydney, NSW 2000
Australia
Tel: 1800 012 612
Entyvio is supplied in New Zealand by:
Takeda New Zealand Limited
Level 10, 21 Queen Street
Auckland 1010
New Zealand
Tel: 0508 169 077
This leaflet was prepared in December 2023.
ENTYVIO® and the ENTYVIO Logo® are registered trademarks of Millennium Pharmaceuticals, Inc., a Takeda company.
TAKEDA® and the TAKEDA Logo® are registered trademarks of Takeda Pharmaceutical Company Limited.